Quest PharmaTech Inc (QPT : TSX-V)
Common Stock
$0.03
CAD
+0.01 (25.00%)
Last updated: 2026-07-20
QPT
Quest PharmaTech Inc
WealthAwesomePerformance
1 Day
+25.00%
1 Week
+25.00%
1 Month
-28.57%
YTD
-28.57%
Key Statistics
Market Cap
$3.38M
52W High
$0.05
52W Low
$0.02
P/E Ratio
0.67
50 Day MA
$0.03
200 Day MA
$0.04
Beta
-0.30
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 1,000 |
| 7/17/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 2,000 |
| 7/16/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 2,250 |
| 7/10/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 155,100 |
| 7/9/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 1,600 |
| 7/6/2026 | $0.02 | $0.03 | $0.02 | $0.03 | $0.03 | 192,998 |
| 7/3/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 15,000 |
| 7/2/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 5,000 |
| 6/30/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 42,901 |
| 6/29/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 99,075 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on QPT's historical volatility
30-Day Vol
241.7%
Annualized
90-Day Vol
207.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.05 |
| 60 trading days | C$0.02 | C$0.01 – C$0.07 |
| 90 trading days | C$0.02 | C$0.00 – C$0.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Quest PharmaTech Inc
Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-814,313
- Profit Margin
- 0.00%
- ROE (TTM)
- 20.91%
- EPS (Diluted)
- 0.03
- Book Value
- 0.16
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About QPT
Articles Featuring QPT.V
Latest articles and analysis covering QPT.V
